Home > Healthcare > Blepharoplasty Market
Blepharoplasty Market Size
Blepharoplasty Market size is poised to expand significantly between 2024 and 2032, attributed to the rising awareness about the benefits of eyelid surgery, including vision improvement and dark circles removal, among others.
As per American Society of Plastic Surgeons, in 2022, the United States witnessed a total of 26.2 million cosmetic and reconstructive procedures, both surgical and minimally invasive, reflecting a significant demand for aesthetic enhancements. The inclination to refine facial aesthetics, intertwined with the pervasive influence of social media and celebrity culture, is leading to a significant uptick in blepharoplasty procedures globally. Moreover, the transparency of celebrities and influencers about their cosmetic transformations further normalizes such procedures, fostering a cultural shift towards embracing cosmetic interventions to attain desired aesthetic outcomes.
Blepharoplasty Market Trends
Rising disposable incomes, particularly in emerging economies, are enabling more people to afford elective cosmetic procedures like blepharoplasty. Moreover, the growing trend of medical tourism is driving the demand for blepharoplasty procedures, as patients seek high-quality healthcare services at lower costs in countries offering advanced medical facilities and skilled healthcare professionals.
Blepharoplasty Market Analysis
The upper eyelid blepharoplasty procedure segment is anticipated to record considerable revenue from 2024 to 2032, due to its effectiveness in addressing aging-related concerns such as drooping eyelids and excess skin. This procedure is particularly popular among older adults seeking to improve their facial aesthetics and restore a more youthful look. With advancements in surgical technology, upper eyelid blepharoplasty procedures have become safer, more precise, and less invasive, contributing to their growing popularity among patients.
The ambulatory surgery centers segment is anticipated to expand at a decent pace till 2032, driven by the growing adoption of minimally invasive methods and the increasing availability of modern technology and skilled specialists in these facilities. Moreover, low costs, increased safety, high convenience, and better accessibility of ASCs as compared to hospital settings will also accelerate segment expansion during the next ten years.
Europe blepharoplasty market share is estimated to grow substantially through 2032 due to the expanding number of baby boomers and the emergence of eyelid surgery as one of the most popular treatments across the United Kingdom. Moreover, advancements in medical technology and favorable reimbursement policies are favoring the number of blepharoplasty procedures across Europe.
Blepharoplasty Market Share
The competitive landscape of the blepharoplasty industry includes prominent companies such as:
- Bomtech Electronics Co.
- Luminera Derm Ltd.
- ThermiGen LLC
- Levadent, Ltd.
- GTG Wellness
- IOPtima
- Advance Medical Systems, Inc.
- Grand Aespio, inc.
These companies are employing various strategies like product innovations, partnerships, R&D investments, collaborations, mergers, and acquisitions to bolster their growth in the industry.
Blepharoplasty Industry News
- In 2024, AbbVie bolstered biologics manufacturing in Singapore with a $223 million investment.
- In September 2023, Genetic Technologies Limited, a prominent figure in genomics-based tests for health, wellness, and critical diseases, unveiled its collaboration with Gold Coast Private Hospital (GCPH), a Healthscope affiliate, to establish a Precision Medicine Clinic within the hospital premises.